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Abstract  
The differential diagnosis of Parkinson’s Disease (PD) remains challenging with frequent mis 
and underdiagnosis. DAT-Scan has been a useful technique for assessing the lost integrity 
of the nigrostriatal pathway in PD and differentiating true parkinsonism from mimics. 
However, DAT-Scan remains unavailable in most non-specialized clinical centres, making 
imperative the search for other easy and low-cost solutions.  This dissertation aimed to 
investigate the role of inertial sensors in distinguishing between the denervated and the non-
denervated individuals.  
In this dissertation, we've used Inertial Sensor Based 3D Full Body Kinematics (FBK) 
and tested if this technique was able to distinguish between patients with changes in the 
DAT-Scan from those without. This was divided into two parts, being that firstly, a group of 
individuals was referred by the attending physician for DAT-Scan (123I-FP-CIT SPECT) to be 
able to compare FBK in those with and without evidence of dopaminergic depletion. Second, 
it was tested whether FBK could be used as a metric for the severity of dopaminergic 
depletion. 
Twenty-one patients participated in this study, being recruited from the Nuclear 
Medicine Unit in the Champalimaud Clinical Centre (CCC), Lisbon. Within these 21 patients, 
10 of them had denervation (mean age, 68.4 ± 7.8 years) and the remaining 11 (mean age, 
66.6 ± 7.4 years) did not present denervation.  
The analysis between the worst uptake ratio features and dimensional features, as 
well as the asymmetry indexes in the striatum revealed significant differences between 
denervated and non-denervated individuals. On the contrary, the kinematics did not do it. 
Overall, based on the collected kinematics data, it was identified that there was not any 
significant correlation between the kinematics and the DAT-Scan. What means that these 
kinematics variables were not able to explain the DAT-Scan. On the other hand, it was also 
checked that the kinematics data were strongly correlated to the motor symptoms (MDS-
UPDRS III). 
This way, it was concluded that the classical biomechanics did not distinguish 
denervated from non-denervated individuals. Therefore, the kinematics could not give the 
same answer as the DAT-Scan. In spite of these results it would be relevant to keep 
researching other methods in order to find out the distinction between the denervation and 
no denervation in a low-cost way.  
 
Keywords: Parkinson’s Disease, DAT-Scan, Inertial Sensors, Motion Capture System, 
Kinematics.  
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Resumo 
O diagnóstico diferencial da doença de Parkinson (DP) permanece desafiador com 
frequentes erros de diagnóstico e subdiagnóstico. O DAT-Scan tem sido uma técnica útil 
para avaliar a perda da integridade da via nigrostriatal na DP e diferenciar o parkinsonismo 
verdadeiro das outras síndromes parkinsonianas. No entanto, o DAT-Scan permanece 
indisponível na maioria dos centros clínicos não especializados, o que torna imperativa a 
busca por outras soluções fáceis e de baixo custo. Esta dissertação teve como objetivo 
investigar o papel dos sensores inerciais a distinção entre indivíduos desnervados e não 
desnervados.   
Nesta dissertação, usámos a cinemática de corpo inteiro (FBK) 3D baseada em 
sensores inerciais e testámos se essa técnica era capaz de distinguir entre pacientes com 
alterações no DAT-Scan daqueles sem. Esta foi dividida em duas partes. em primeiro lugar, 
um grupo de indivíduos foi encaminhado pelo médico assistente para o DAT-Scan (123I-FP-
CIT SPECT) para poder comparar a FBK naqueles com e sem evidência de depleção 
dopaminérgica. Segundo, foi testado se a FBK poderia ser usada como uma métrica para a 
severidade da depleção dopaminérgica.  
O estudo incluiu 21 pacientes da Unidade de Medicina Nuclear do Centro Clínico 
Champalimaud (CCC), em Lisboa. Desses 21 pacientes, 10 deles apresentaram 
desnervação (idade média de 68,4 ± 7,8 anos) e os restantes 11 (idade média de 66,6 ± 7,4 
anos) não apresentaram desnervação. 
A análise das piores taxas de absorção e das características dimensionais no 
estriado, assim como os índices de assimetria revelaram diferenças significativas entre os 
indivíduos desnervados e não desnervados. Pelo contrário, a cinemática não. No geral, com 
base nos dados cinemáticos recolhidos, verificou-se que não havia uma correlação 
significativa entre a cinemática e o DAT-Scan. O que significa que as variáveis cinemáticas 
usadas não podem explicar o DAT-Scan. Por outro lado, os dados também mostraram que 
a cinemática está fortemente correlacionada com os sintomas motores (MDS-UPDRS III). 
Assim, concluiu-se que a biomecânica clássica não distingue os indivíduos 
desnervados dos não desnervados. Pelo que, a cinemática não pode dar a mesma resposta 
que o DAT-Scan. Apesar destes resultados, será relevante continuar a investigar outros 
métodos para distinguir entre denervação e não-denervação de uma maneira económica. 
 
Palavras-chave: Doença de Parkinson, DAT-Scan, Sensores Inerciais, Sistema de Captura 
de Movimento, Cinemática.  
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1 Introduction 
1.1 Motivation  
The nervous system plays an important role in the human body once it affects the sensory 
and motor functions. Therefore, the research on the neural development is of great 
importance to improve understanding of the brain functions and the human illnesses. Any 
disturbance on the neuronal connectivity can lead to brain dysfunction and diseases, such as 
idiopathic Parkinson’s disease (PD) [1] that is one of the forms of Parkinsonism. 
Parkinsonism is a term that covers several conditions such as PD and other neurological 
conditions with similar symptoms for example: slowness of voluntary movements 
(bradykinesia), rigidity and problems with walking [2]. Parkinson’s disease is a 
neurodegenerative brain disorder where some nerve cells break down slowly or die. The 
symptoms include an ongoing damage of motor control, once they are due to a loss of the 
neurons that produce a chemical messenger in the brain called dopamine (DA). When its 
levels decrease it causes the abnormal brain activity, leading to the symptoms of PD. These 
symptoms can take years to develop and most people live for many years with the disease 
[3].  
Currently, the prevalence of PD includes 180 cases per 100 thousand inhabitants in 
people over 50 years in Portugal [4]. It is estimated that the number of people with this 
disease will increase in the coming decades worldwide [5], [6].  
The Parkinson's disease is usually diagnosed clinically by the presence of 
parkinsonism, i.e., bradykinesia plus some other motor symptoms (MS). However, when the 
MS appears clinically, there has already been a 50% reduction in the dopaminergic 
nigrostriatal cells [7]. Today the most common used method to exclude the PD is the DAT-
Scan, allowing to observe the integrity of the dopamine transporters (DATs). The DAT-Scan 
is a medical examination that can not only provide the information for the patients suspected 
of having a dopaminergic deficiency but it can also discriminate the parkinsonian syndromes 
(PSs). Still, this method is very expensive, slow, and mostly analyzed by the qualitative and 
the subjective ratings obtained by the human interpretation of the presentation of the disease 
signs and the symptoms at the clinical visits [8]. 
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In recent years, gait analysis has demonstrated effectiveness in pre-treatment 
evaluation, surgical decision making, postoperative follow-up, and management of patients. 
It is known that human locomotion involves the integration of intricate sensory information 
within the nervous system, resulting in motor commands to control muscle contraction and 
subsequent joint movement [9], [10]. 
The quantitative, objective, and easy wearable sensors (e.g. inertial sensors) have 
been also developed for quantifying PD signs. They are smart electronic devices with 
microcontrollers that can be incorporated into clothing or worn in the body as implants or 
accessories which enable to exchange data, without requiring human intervention. These 
devices have the potential to improve significantly both clinical diagnosis and management in 
PD and the conduct of clinical studies. This technology allows relevant measurements 
through a cheap, reliable and validated disease process [11].  
In this context, it is relevant to apply kinematic models in the inertial sensors to make 
an assessment as far as concerned the balance and the gait abnormalities in the early 
stages of the PD. As a motivation, it is expected that the inertial sensors can answer at the 
same mode as the DAT-Scan because it is an inexpensive and quick method.  
 
 
1.2 Objectives and Dissertation Structure 
The main goal of this work is to distinguish between individuals with and without denervation, 
whose diagnosis is unknown, as defined by the DAT-Scan result, through the use of full body 
kinematics (FBK). The secondary objective is to determine if there is a kinematics 
relationship with the dopaminergic system.  
 
The dissertation is structured as presented as follows: 
• Chapter 1 describes the motivation of the study, the aim and objectives of the 
research. 
• Chapter 2 provides a brief introduction to Parkinson’s disease and related problems. 
The reader will be presented with an explanation about the technique, properties 
and utility of DAT-Scan. The role of DAT-Scan in the diagnosis of Parkinson’s and 
the problem of the use of DAT-Scan. It also describes the concepts related to gait 
assessment, kinematics and inertial sensors.  
• In chapter 3, the materials and methods used for the kinematics analysis and for the 
imaging processing are presented.  
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• Chapter 4 contains the results of this study.  
• Chapter 5 indicates the overall discussion and the limitations from this dissertation 
work.  
• Finally, chapter 6 presents the conclusions and future perspectives which 
summarize the dissertation’s findings and it suggests the next steps of this study. 
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2 Literature Review 
This chapter provides a brief introduction about Parkinson’s disease. It provides some notion 
about the concepts of 123I-FP-CIT SPECT, gait analysis, kinematics and motion caption with 
inertial sensors.  
 
2.1 Parkinson’s Disease 
The Parkinson’s disease (PD) is a slow, progressive and neurodegenerative disorder, with 
no cure currently. The PD is characterized by the neural degeneration in the specific brain 
regions, such as the dopaminergic neurons of the substantia nigra pars compacta (SNpc). 
That means it occurs the progressive loss of the dopaminergic neurons within the SNpc and 
their axon terminals in the striatum [12].  
The substantia nigra (SN), which is placed in the midbrain, constitutes a part of the 
basal ganglia (BG) that is a highly organized network, where the different regions of the brain 
are activated. That one coordinates multiple aspects of the cognition, such as: controlling 
movement through their connections with the motor cortex and providing associative 
learning, planning, working memory, and emotion. The main components of the BG are in 
the striatum. This last one is constituted by the caudate nucleus and the putamen. The 
caudate nucleus is one of the structures that makes up the corpus striatum, and the putamen 
is a round structure located at the base of the forebrain [13].  
SNpc sends messages to the striatum via neurons that are rich in the 
neurotransmitter dopamine (DA), forming the nigrostriatal pathway, which helps to stimulate 
the cerebral cortex and initiate movement. In Figure 2.1 is shown how it is passed the 
information via neurons. The information is conveyed through two kinds of neurons: the 
presynaptic and the postsynaptic ones.  
The presynaptic neurons are constituted by store vesicles, where DA is stored and, 
subsequently, released through the dopamine transporters (DAT). DAT is a sodium chloride 
dependent protein in dopaminergic terminals and it is responsible for the reuptake of 
dopamine from the synaptic cleft back to the presynaptic neurons at the moment of 
information transmission. This DA is not all lost because it is captured in the presynaptic 
neurons by the DAT and re-storage, after being released by dopamine receptors of 
postsynaptic neurons [14],[15].  
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2.1.1 Characteristics of the Parkinson’s Disease 
The cause of PD is usually unknown (idiopathic). However, the lifestyle, the environmental 
and the genetic factors are considered etiological determinants. Moreover, the advanced age 
is another significant risk factor [16]. It is generally considered that known genetic causes 
may be relevant in more than 5% of the total PD population, but some propose that 
monogenetic causes may be involved in as many as 5–10% of the PD population [5].  
The clinical diagnosis of classic PD is based on identifying clinical characteristics 
related to striatal dopamine depletion that typically manifest as motor signs and symptoms 
(MS) - bradykinesia, tremor, rigidity, and postural instability - which are accompanied or often 
even preceded by non-motor symptoms (NMS) [16]. These MS just appear after a 50-70% 
reduction of striatal dopamine which corresponds to 50% cell death of dopaminergic neurons 
of the SNpc. Patients with PD present first with unilateral symptoms but gradually it can 
progress involving both sides [17]. However, these ones may not all be present.  
 
 
 
Figure 2.1 | Schematic representation of dopaminergic neurotransmitter system [14].  
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The symptoms referred above are going to be described: 
Bradykinesia is also known as a slowness of movement and it is the most common 
symptom of PD, because it is necessary for the diagnosis. It is responsible for inducing 
difficulties with rapid repeated movements [18]. Beyond the slowness in performing activities 
of daily living, the slow movement and the reaction times, bradykinesia presents other 
manifestations like the loss of spontaneous movements and gesturing, loss of facial 
expression, decreased blinking and reduced arm swing while walking [19].  
A tremor is an involuntary trembling movement or shake. Characteristically occurring 
at rest, the classic slow, rhythmic tremor of Parkinson’s disease typically starts in one hand, 
foot, or leg and can eventually affect both sides of the body. The tremor that occurs in 
Parkinson’s disease is different from almost all other tremors because it is a “resting tremor”, 
present primarily at rest. It goes away with movement but often returns when the limb is held 
in one position, as in holding a spoon or fork to the mouth, which is why those with 
Parkinson’s are known to spill things. Parkinson’s disease tremor may affect almost any part 
of the body, but most commonly involves the fingers, followed next most commonly by the 
hands, jaw, and feet [20]. It occurs when a body part is totally supported at rest and tends to 
stop when an intended action is carried out. It can affect the hands, legs, lips, and tongue 
[19].  
Rigidity occurs when there are series of catches or stalls as a person’s arms or legs 
are passively moved by someone else. It is characterized by increased resistance, once the 
muscles become rigid because of their inability to relax. It may occur both at the proximal 
level, for example in the neck, shoulders, and hips, as well as at the distal level, such as the 
wrists and ankles [21]. The rigidity can limit muscles from stretching and relaxing as they 
should. It can manifest at the level of rigid muscles through reduced facial expression, 
difficulty turning when walking, in bed and getting out of a chair or bed, reduced arm swing 
when walking and difficulty with everyday activities such as dressing, cutting food and 
writing, for example [20]. 
Finally, postural instability is due to the loss of postural reflexes, which are usually a 
manifestation of the late stages of PD that may occur after the appearance of other clinical 
features. It causes problems with balance and can lead to falls. Other parkinsonian 
symptoms, orthostatic hypotension, age related sensory changes and the ability to integrate 
visual sensory input are several features that influence the occurrence of postural instability 
[19]. 
As mentioned above there are also NMS of PD including behavioral and psychiatric 
problems such as: dementia, psychosis, cognitive impairment, addiction and compulsion, 
depression and anxiety, fatigue, gastrointestinal and olfactory dysfunction. Yet, there are 
other neurodegenerative diseases when these clinical features appear, which means that it 
is hard to diagnose PD [22]. 
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2.1.2 Differential Diagnosis Problem of Parkinson’s Disease 
The different causes of parkinsonism can be classified into two distinct groups: diseases with 
nigrostriatal cell loss such as Parkinson’s disease (PD), Progressive Supranuclear Palsy 
(PSP), Multiple System Atrophy (MSA), Corticobasal Degeneration (CBD), and Dementia 
with Lewy body (DLB) and diseases without nigrostriatal cell loss such as Drug-Induced 
Parkinsonism (DIP), Essential Tremor (ET), Vascular Parkinsonism (VP) [8]. 
Progressive Supranuclear Palsy is sometimes misdiagnosed as Parkinson’s disease 
because of the similarity to some symptoms during the early stages of the disease, such as: 
rigidity, bradykinesia, and movement difficulties. However, PSP progresses much faster, 
causes more severe symptoms, and it has a significantly reduced life expectancy. There are 
notable differences in people with PSP, for instance: people find it hard to look up or down, 
whereas people with PD may experience other eye-related problems, including double 
vision, uncontrolled blinking or excessive watering; it concerns posture, people with PSP 
tend to stand straight or tilt their heads backward, while people with PD usually bend 
forwards; the tremor that is almost universal in people with PD is rare in PSP, etc. [23]. 
 Multiple System Atrophy is often mistaken for Parkinson as it tends initially to 
present similarities because it presents problems, particularly related to movement, balance 
and other autonomic body functions. Besides that, MSA progresses faster. According to 
some studies the degree of loss was higher in putamen than caudate in both PD and MSA 
patients. However, MSA patients showed a more symmetric loss of striatal DAT in both 
caudate and putamen than PD patients and MSA patients had significantly increased 
distribution volume ratios (DVRs) in the posterior putamen compared with PD patients [24].  
Dementia with Lewy bodies are the pathological hallmark of Parkinson’s disease. 
Both DLB and PD are characterized pathologically by the presence of Lewy bodies 
(abnormal aggregates of protein that develop inside nerve cells), though in PD patients there 
is greater neuronal loss within the SN whereas in DLB patients there is greater cortical β-
amyloid1 deposition. In PD they appear in the SN in the midbrain, while in DLB they are more 
widely distributed throughout the cerebral cortex. People with DLB may have stiff muscles, 
slow movement and tremor like someone with PD [16]. 
Other diseases, for example, DIP, ET, or vascular parkinsonism (VP) also share 
common features with PD [25].  
 Drug-Induced Parkinsonism is developed when patients are treated with neuroleptic 
or dopamine receptor blocking agents. The differentiation between PD and DIP is difficult to 
assess in clinical grounds alone.  
 
1 β-amyloid are protein fragments that are toxic to neurons and their synapses [16].  
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Essential Tremor is a slow common condition that results in trembling in the hands 
or arms, which in some cases can subsequently spread to cause tremor of the head, legs, 
trunk or voice [26]. It is quite often confused with Parkinson’s disease since people with 
Parkinson also experience tremors, but in PD the trembling is usually more apparent when 
the hands are resting on the affected person’s lap or when walking. It also appears first in ET 
shaking in both hands but tremor usually starts in one side of the body in PD, typically 
beginning in a hand, and then it spreads to the rest of the body. There are also other signs in 
PD that are not seen in ET, for instance: rigidity, bradykinesia or gait disturbance. 
Sometimes, it is difficult to distinguish between PD and ET and misdiagnoses have been 
made [27], [28]. 
 A possible diagnosis of PD may be confirmed by the appearance of MS associated 
with the degeneration of nigrostriatal dopaminergic neurons or if the person responds 
positively to medication for Parkinson. This is different from what happens with atypical 
parkinsonian syndromes (APSs) (e.g., PSP, MSA, CBD, and DBL) that are characterized by 
poor response to antiparkinsonian medication and rapid clinical deterioration, which are often 
confused with PD [29].  
Thus, the differential diagnosis of PD is extensive. There is no definite test to confirm 
the cause of parkinsonism in clinical practice. Misdiagnoses can occur because symptoms 
vary from person to person and there is a number of other diseases that have similar 
symptoms [30]. 
 
2.1.3 Monitoring the Progression of the Parkinson’s Disease 
The rate of progression of dopaminergic degeneration is much faster in PD than in normal 
aging. Pathologic studies investigating the rate of PD progression have been limited to 
patients with severe illness of long duration and rely entirely on cross-sectional data. The 
stage and severity of PD is an important factor to consider for taking effective therapeutic 
decisions [25]. 
There are many scales to evaluate impairment disability of motor impairment, as well 
as to monitor disease progression in patients with PD. Among these, the most well-
established scale is the Unified Parkinson's Disease Rating Scale (UPDRS). The Movement 
Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS) is the updated 
and revised version of the original UPDRS with new items devoted non-motor elements of 
PD. It provides a comprehensive assessment of the clinical features, both motor as well as 
non-motor, and it is a flexible tool to monitor the course of PD and the degree of disability. 
This last one, it will be used in this study but only be considering the part referent to the 
motor function. The progression of PD usually starts from unilateral (Stage 1), to bilateral 
without balance difficulties (Stage 2), followed by the presence of postural instability (Stage 
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3), to loss of physical independence (Stage 4), and being wheel-chair or bed-bound unless 
aided (Stage 5).  The MDS-UPDRS scale allows to categorize PD as early stage (Stage 1 
and 2), moderate stage (Stage 3) and late stage (Stage 4 and 5). This scale consists of four 
parts. Part I assesses the non-motor experiences of daily living, i.e., evaluate mental activity, 
behaviour, and mood. Part II regards to motor activities of daily living such as: speech, 
swallowing, handwriting, dressing, hygiene, falling, salivating, turning in bed, walking, and 
cutting food. Part III is motor examination, which means that it evaluates the motor function. 
Part IV assesses motor complications such as dyskinesias and motor fluctuations which are 
strongly related to the duration of disease, and the duration of levodopa treatment [31]. 
Longitudinal studies show that UPDRS scores increase over time, which may be 
crucial to clinical decision making, particularly in need to introduce symptomatic therapy. It is 
also known from these studies that the MDS-UPDRS scale is strongly correlated with the 
original UPDRS and the other disability measures, quality of life scales and disease duration, 
what makes the former be more sensitive to changes in PD than the original one. Therefore, 
the MDS-UPDRS provides a wide spectrum of assessments and it is a reliable and sensitive 
instrument for estimating the progression and severity in PD [32].  
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2.2 123I-FP-CIT SPECT 
2.2.1 Technique and Properties 
Imaging of the DAT with 123I-FP-CIT (commercially available as DAT-ScanTM) and single-
photon emission computed tomography (SPECT) is the most widely used nuclear medicine 
technique for routine confirmation of dopaminergic degeneration during the assessment of 
patients with suspected degenerative parkinsonism [33].  
This test consists of two steps: Firstly, it is given an 123I-Ioflupane injection, radioactive 
decay of 123I-Ioflupane emits γ radiation, that tags the dopamine transporters. The main 
metabolic product of 123I-Ioflupane is FP-CIT acid, a polar compound that is unable to cross 
the blood-brain barrier [34]. Secondly, it involves a γ camera (Figure 2.2) [35], which records 
the iodine radioactivity of several DAT-rich subregions of the brain through images showing 
the location and density of dopamine cells [36].  
Thus, the 123I-FP-CIT SPECT shows how blood flows to tissues and organs, and it 
allows for detecting the loss of dopaminergic neurons.  
 
Figure 2.2 | Example of DAT-Scan device [35]. 
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DAT-Scan is available only with a medical prescription and it is indicated for adult patients 
who have parkinsonian syndrome (PS) symptoms. The radioactive exposure and risk 
associated are somewhat small (the amount of radiation as similar to regular x-rays). Forty-
eight hours post-injection, about 60% of the injected radioactivity is excreted in the urine 
about 14% in fecal excretion. Potential side effects include headache, nausea, stomach 
upset, dry mouth, and dizziness [37]. 
2.2.2 The Clinical Utility of DAT-Scan 
The progressive degeneration of nigrostriatal dopaminergic neurons can be assessed by 
using radioligands in imaging-based approaches. DAT imaging can afford information in 
patients suspected of having a dopamine deficient degenerative parkinsonian syndrome and 
discriminate this from alternative diagnoses. It can be useful for assessing whether striatal 
dopamine deficiency is present in patients with suspected PD who are not responding to 
therapy as well as it might be hoped. Additionally, it can also potentially be used to detect 
subclinical striatal dopamine deficiency in subjects at risk for developing PD, even though, in 
the absence of an effective neuroprotective agent, the value of this remains uncertain [26], 
[38].  
The dimensions of the striatal uptake region, especially the length from the caudate 
head (most anterior) to the most posterior putamen contours, are key factors in the visual 
assessment of the 123I-FP-CIT SPECT brain images made by physicians.  
For each side of the striatum, the specific binding ratio (SBR) represents the ratio 
between the counts concentration in the striatum due to the specific binding only and the 
count concentration in the reference region due to the free and nonspecific binding, and it is 
given by:  
 
 
Where  is the volume of a single voxel,  is the volume of the striatum,  is 
the total count in the large striatum region of interest (ROI), R is the mean count per voxel 
within the reference ROI, and  is the volume of the large striatum ROI in numbers of 
voxels [39], [40].  
This medical examination shows whether there is a greater uptake in the putamen 
(early stages of PD) or in the putamen and caudate (early stages of ET) allowing distinguish 
PD from ET, for example. Therefore, DAT-Scan provides a potential tool to evaluate patients 
with unclear PS symptoms, and it also contributes to accurate clinical management of the 
patient and prevention of unnecessary medications and procedures [25]. 
 
 
 
 
Inertial sensor based full body 3D kinematics in the differential diagnosis between 
Parkinson’s Disease and mimics 
___________________________________________________________________ 
13 
 
 
2.2.3 The Role of DAT-Scan in the Diagnosis of Parkinson’s 
Disease 
As mentioned previously, SPECT imaging using 123I-Ioflupane (123I-FP-CIT SPECT) is 
commonly used for diagnosis PD, once provides information based on local binding of 
presynaptic DATs. This binding measure is quantitative and assesses the spatial distribution 
of DATs. The decrease of 123I-FP-CIT specific uptake in the putamen excludes the diagnosis 
of other diseases running with no dopaminergic degeneration, such as essential tremor (ET) 
or drug-induced parkinsonism (DIP) [41]. Consequently, DAT-Scan can differentiate 
Parkinson’s from ET or DIP (movement disorders that do not affect the dopamine cells). 
When, for example, it's hard to tell whether a person's shaking is from essential tremor or 
Parkinson's, DAT-Scan may be used to separate the two conditions, which have different 
treatment options and prognoses [42].  
 However, any disease that causes loss of presynaptic dopamine neurons will appear 
as abnormal compared with normal controls. Thus, 123I-FP-CIT SPECT is not able to 
differentiate among PD, PSP, MSA, CBD and other neurodegenerative disorders that affect 
the dopamine neurons, which mean DAT-Scan cannot be used on its own to diagnose 
Parkinson's because conditions other than Parkinson's decrease dopamine activity and 
cause abnormal images [43], [44].  
 
2.2.4 The Problem of Using DAT-Scan 
123I-FP-CIT SPECT is useful for the differentiation of PD from disorders without presynaptic 
dopaminergic terminal deficiency (e.g. ET or VP) and it is non-invasive. However, it presents 
some disadvantages. 
From a clinical point of view, a factor that weakens the robustness of 123I-FP-CIT 
SPECT is the fact of its assessment to be made in a subjective visual way. Even though, 
objectivity may come through a ROI approach or voxel-based techniques that can improve 
its wide clinical use. In spite of that, it cannot distinguish PD from other disorders associated 
with SNpc neurodegeneration (e.g. PSP, MSA, CBD or DLB).    
 From a methodology point of view, there are several methods to quantify 123I-FP-CIT 
SPECT images that can assist the diagnosis of PSs such as ROIs, one-shape analysis of 
the uptake, Statistical Parametric Mapping (SPM) analysis based on background ratios, 
principal component analysis, and machine learning (that can be applied to the SPECT 
images through computer-aided diagnosis systems).  
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From a costs point of view, 123I-FP-CIT SPECT is very expensive. But, the cost of SPECT 
imaging is much less compared to other functional imaging techniques such as Positron 
Emission Tomography (PET) [34], [45].  
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2.3 Gait Analysis and Kinematics 
Gait analysis studies human locomotion and it is very useful for a better understanding of the 
mechanisms of movement disorders. It is possible to determine the kinematics and kinetics 
parameters of human gait through it. It can also estimate physiological gait parameters, i.e., 
spatiotemporal parameters (cadence, step length, gait asymmetry, etc.), and evaluate 
quantitatively the musculoskeletal functions [11].   
The interest in the analysis of movement and especially in gait analysis began in the 
ancient times, through observation, by Aristotle, Hippocrates, Galen, Leonardo da Vinci, and 
Honoré de Balzac to analyse the gait of human beings with [46].  
The interest in the analysis of human gait emerged owing to motion analysis, 
provided information possibly pathological processes that are not directly perceptible except 
by using deeply invasive procedures [47]. It was only in the second half of the 18th century 
that were published papers on the biomechanics of human gait [48]. 
Research on gait analysis has been conducted since the late 19th century, and the 
general application of gait analysis to humans with pathological conditions such as 
Parkinson’s Disease began in the s, with the technological advances which allowed the 
production of detailed patient studies [49].  
In the last decades, the measuring and recording techniques for capturing gait 
patterns have improved a lot and gait analysis of human movement. Consequently, gait 
analysis has its applications presently in almost all significant fields of human locomotion. It 
has been a fundamental method and assistive tool to characterize human locomotion in the 
field of biomedical engineering [50], [51].  
 
2.3.1 Gait in Parkinson’s Disease 
Gait is defined as a pattern of walking. While a “normal gait” is characterized by an upright, 
by an even stride and by arms swinging at the sides, a “Parkinsonian gait” is defined as 
having a less steady walk that results from changes in posture, slowness of movement 
(bradykinesia) and a shortened stride [52].  
As discussed previously, the exact diagnosis of PD may be delayed in early stages, 
as structural neuroimaging methods do not provide characteristic features to allow the 
diagnosis of PD [53]. In the early stages of PD, many gait alterations become apparent when 
patients walk or do another task at the same time. These changes are noticeable, for 
instance, in the gait which is slow, in the step length that shortens, in the reduced arm swing 
amplitude and the smoothness of movement compared to healthy age-matched people. The 
symptoms are often unilateral, corresponding to asymmetrical basal ganglia neuropathology. 
Therefore, gait analysis may help PD diagnosis [54], [56].  
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Gait analysis can be characterized by biomechanical engineering, which involved the 
measurement, analysis, and assessment of the biomechanical features that are associated 
with the walking task [57], and used for two very different purposes: to aid directly in the 
treatment of individual patients and to improve our understanding of gait through research 
[50]. It performs an important role in supporting human mobility and it is a relevant tool for 
obtaining quantitative information on motor deficits in PD, allowing the clinician to assess the 
degree of abnormality and to reassess the effectiveness of treatment [55], [58]. For this 
reason, gait analysis needs a biomechanical model that will indicate the positions of the body 
segments from the areas measured by the markers placed on the skin.    
 
2.3.2 Kinematics and Kinetics 
In general, the physical ways to analyse gait are based on kinematics and kinetics. Then, 
gait analysis is considered an acceptable tool for kinesiology analysis of movement 
disorders, including for evaluating gait and posture disturbances, once their data are applied 
to the model for the analysis of gait patterns and behaviour. Kinematics and kinetic data 
represent fundamentally the locomotion pattern of the human musculoskeletal system in 2D 
or 3D environment [59], [60]. 
Kinematics describes the body motion without consideration of the fundamental 
forces responsible for the movement. It focuses on the study of the relative movement 
between body segments. Kinematics parameters include measurements of the position and 
orientation of the body segments, joints angles and the corresponding linear and angular 
velocities and acceleration [57]. Kinematics data are valuable in the analysis of gait 
disorders. However, they do not provide information on biomechanical efficiency, ground 
reaction forces, joint moments, or joint powers. Furthermore, kinematics data can be 
supplemented with temporal and stride events that include cadence, walking speed, stride 
time, stride length, step time, step length, period of single limb support, and period of double 
limb support [48].  
A part of kinematic variables control, which is related to planning and decision 
making, is the Inverse Kinematics (IK) problem, which is to calculate the inverse function of 
the forward kinematics. The forward kinematics serves to get coordinate of the end effector 
from given angles of all joints. Contrary to the forward kinematics problem which is 
deterministic, the IK problem has no unique solution for a manipulator with several degrees 
of freedom [61]. Thus, the IK problem will be applied in this study, once it aims at 
determining the angular kinematic variables in the joint configuration space, based on the 
Cartesian kinematic variables of the end-effector [62].  
On the other hand, kinetics study the motion with consideration of the underlying 
forces that cause the movement. The kinetics analysis uses reaction forces, joint forces, 
moments, and powers from the movement and impact of the musculoskeletal system of the  
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human body. These forces include the external ground reaction forces and the internal joint, 
muscle, and ligamentous forces [63]. 
 
2.3.3 Motion Capture System 
Technological advances produced relatively low-cost tools, such as inertial sensors that 
rapidly replacing complex camera-based motion capture systems, allowing clinicians to 
quantitatively assess gait. They have been widely applied to the problem of the recognition 
of the gait where the gait evaluated can be interpreted as a biometric trace [64]–[66]. 
One of the well-known techniques of gait analysis is the use of motion capture 
camera. This one can be used to provide comprehensive, objective measurements such as: 
joint positions, joint motion trajectories, and joint angle variations during walking. However, 
this equipment is expensive, non-portable, requires a high level of technical expertise and a 
lengthy calibration process. Usually, the clinicians do not have access to objective 
biomechanical information for assessing patient performance and as such, the use of these 
systems is not widespread in clinical practice [57].   
A potential solution to this problem is the inertial measurement units (IMUs), which 
could be used in clinical settings to objectively measure movement patterns during functional 
activities. These systems are more and more available, from companies such as Xsens 
Technologies B.V., (Enschede, The Netherlands) and will be used in this study [67],[68].  
These IMU are devices constituted by three dimensional (3D) accelerometers and 
3D gyroscopes. They are used for the detection of human movements. Accelerometers 
detect movement, measure the force of acceleration along a given and transforms the 
mechanical signal into an electric one. They work by two components: Direct current (DC), 
which senses the gravity effect and uses it to determine the position of the body, and 
alternating current (AC) that represents the voluntary movement. Gyroscopes are ideal to 
detect the angular velocity of a rotating body and they are subject to less mechanical noise 
[69]. When both combined together, turning is better evaluated with less motion dynamic 
artifact, once accelerometer can be used to compensate the drift of the gyroscope about the 
axes of the horizontal plane [70]. Therefore, the data from accelerometers and gyroscopes 
provide the facilities to analyse human locomotion in 3D environment [64].  
Compared to motion capture camera the sensors can allow to estimate with great 
accuracy and reliability the full-body kinematic motion parameters, as well as the position, 
the speed, and the acceleration produced by the movement. They are small, lightweight, and 
capable to detect a large range of angular velocity and acceleration, portable and less 
expensive than traditional camera-based motion-capture systems [70], [72]. However, 
sometimes it could be difficult to identify the exact length of the segment, rotational axis and 
different positions of sensor attachments, showing variations in acceleration sensing [64]. 
 
 
Inertial sensor based full body 3D kinematics in the differential diagnosis between 
Parkinson’s Disease and mimics 
___________________________________________________________________ 
18 
 
 
The biomechanical models afford a non-invasive means through the IMUs to study 
human movement and predict the effects of interventions in the gait. These models can 
deliver different types of relevant information (the 3D body segment kinematics, the 
spatiotemporal locomotion parameters and the locomotion patterns) in real-time [73]. They 
can be applied to using some contact points defined through the lowest body models or in 
the full-body models, for instance.   
The lowest body model provides accurate 3D segment orientation estimates for the 
lowest body based on the inertial motion capture method tracking the 3D kinematics of the 
pelvis, the upper legs, the lower legs and the feet [74]. The 3D full-body model based on the 
inertial motion capture method includes 15 segments: head, chest, arms, forearms, hands, 
pelvis, upper legs, lower legs, and feet [75]. 
These models allow maintaining a good average 3D kinematics estimation error in 
the low and the high acceleration locomotion. However, the 3D full-body model can give 
more information than the lowest limbs model. 
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3 Methodology 
This chapter provides the experimental details for this study. It presents the population 
dataset, the protocol applied, the DAT-Scan image processing steps, the procedures steps 
for each data collection and the statistical analysis made. The information about equipment 
and software are listed in the Appendix 1 and the  Appendix , respectively.  
 
3.1 Population Dataset 
Twenty-one volunteers participated in the study, being recruited from the Nuclear Medicine 
Unit in the Champalimaud Clinical Centre (CCC), Lisbon. The general inclusion and the 
exclusion criteria are listed as follows: 
 Inclusion Criteria  
- Individuals were referred to DAT-Scan for differential diagnosis of parkinsonism; 
-  ≥18-year-old. 
 Exclusion Criteria  
- Any disorder that could influence walking (e.g. painful arthritis, peripheral 
neuropathy); 
- Any relevant unstable medical condition; 
- Use of a walking aid; 
- Pregnancy; 
- Any contraindication for DAT-Scan (patients referred but found because they 
have a contraindication like known hypersensitivity either to the active 
substance, excipients or to iodine).  
All participants signed a voluntary consent form. The study was approved by the local ethics 
committee and by the Code of Ethics of the World Medical Association (Helsinki 
Declaration).  
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3.2 Data Collection  
3.2.1 Instrumentation  
 A full body configuration was applied using 15 inertial sensors (MVN BIOMECH Awinda, 
Xsens Technologies, Enschede, The Netherlands) with dimensions of 47 x 30 x 13 mm, 
attached with elastic velcro straps positioned throughout the body in order to assess the 
kinematics. The inertial sensors (MTw Awinda) were placed in a similar way to that illustrated 
in the Figure 3.1. Additionally, a static calibration was performed to align the sensor’s 
orientation to the segment’s orientation. This one was done with the participant standing next 
to the Awinda, with the forearms at a 90º degree angle with the arms and the feet parallel to 
each other pointing forward. The position, velocity, acceleration data for each segment were 
then analysed and a set of features of derived were used in the classification system. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1| Example of an individual outfitted with Xsens wearable inertial 
sensor technology:  on head,  on chest,  on arms,  
on forearms, (  on hands,  on pelvis,  on thighs,  on 
legs and  on feet [70]. 
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3.2.2 Feature Extraction 
The selection and extraction of appropriate features were important aspects of the research. 
All the classification results were based on the extracted features. The selected features 
were independent of the location, the direction and the trajectory of the motion studied. It is 
reasonable for the gait to deduce that the most important facets to consider would be the 
legs, the feet and the arms. The features were extracted in a gait cycle for each individual.  
The data produced by the MTw Awinda were stored in a rich detail within an MVNX 
(Moven Open XML format) file which contained the 3D position, the 3D orientation, the 3D 
acceleration, the 3D velocity, the 3D angular rate and the 3D angular acceleration of each 
segment. 
The extracted features chosen were the subtended angles of the following body 
elements: head, chest, left and right arm, left and right forearm, left and right hand, pelvis, 
left and right thigh, left and right ankle and left and right foot. Thirteen features per individual 
were extracted in the total.   
 
3.2.3 Data Analysis 
3.2.3.1 Kinematics 
As mentioned in the previous chapter kinematics gait analysis is concerning with the 
description of gait components. The Link system was used to collect the inertial-based 
spatiotemporal data, i.e., the distance (spatial) and the time (temporal) parameters. Of the 
variables that were collected, four of them could be expressed in time (s), four in distance 
(cm) and the remaining ones in percentage (%).  
 
The time parameters that were collected include the following: the cycle duration, 
which represents the period of time required for an individual to complete a cycle of a lap; 
the step duration that is the period of time required for an individual to take a step; the 
cadence (steps/min) that expresses the number of steps per unit time and the velocity (m/s), 
which characterizes the speed of the path taken by an individual.  
Regarding the distance parameters, it was collected the following: the step length, 
which represents the distance between the first point of contact of a limb (feet) with the 
ground and the first point of contact of the limb on the opposite side; the step height; the step 
width that is measure that is perpendicular to each foot midline, between the initial point of 
contact of one foot and the successive initial point of contact of the opposite foot; and the 
arm swing that is a natural movement where each arm swings with the motion of the 
opposing leg.  
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It was also collected from the variables that can be expressed in percentage the 
following: the support phase duration, which refers to reference limb in contact with the floor; 
the swing phase duration that refers to reference limb, not in contact with the floor; the step 
duration asymmetry; the step length asymmetry and the double support phase, which relate 
to both feet in contact with the floor.  
The three-dimensional acceleration of the inertial sensors was calculated using 
motion capture data and it was transformed into the sensor coordinate system. Then these 
data were time-matched to within 0.01 s of the corresponding raw sensors accelerometers 
data. It was used a custom semi-automatic correlation method which used the cross-
correlation to provide an initial guess and then manual adjustment to find the final 
synchronization point.  
 It was applied the inverse kinematics (IK) instead of forward kinematics because this 
one permits to calculate the correct angles for a desirable position and orientation. 
Therefore, the IK allows to reconstruct the 3D biomechanical model.  
 
 
3.2.3.2 DAT-Scan 
 Firstly, the images were registered in ITK-SNAP library. Next, four regions of interest (ROIs) 
were defined: a large ROI over the whole nonspecific brain region that was used as the 
reference region, and three ROIs on each hemisphere of the brain: one over the putamen 
,another one over the caudate and one large ROI containing the entire striatum and 
surrounding area, as shown in the  Figures 3.2 and 3.3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2| Example of striatal large ROI and reference ROI visualization: on 
the left, an axial plane; middle top, a coronal plane; middle bottom, a sagittal 
plane, and on the right, the scale represents the number of counts per voxel. 
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The shape of these ROIs and their inferior-superior position in the brain were established 
based on the SPECT template. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The computation of the striatal uptake ratios was calculated as well. Then it was built the 
voxel-wise binding potential image and it was done the assessment of the dimensions of the 
striatal uptake region. Finally, the feature vectors were assembled to be used in the 
classification.  
In the end, if there was a normal uptake, this classification would detect a normal 
pattern similar to a healthy control, or if uptake was abnormal, the classification would detect 
an abnormal pattern based on the standardized patterns of PD.  
The results of the DAT-Scan were defined qualitatively and quantitatively. They were 
classified qualitatively by the responsible physician for the nuclear medicine unit from the 
CCC, and quantitatively by the classification referred above that confirms the diagnoses 
made qualitatively. In this way it was possible to create two different labels: individual without 
denervation and individual with denervation, respectively.  
 
The features from the striatum used to help determining, whether there was 
dopamine uptake or not , were the following ones: Uptake ratio-based features (specific 
binding ratio (SBR), caudate binding potential (CBP), putamen binding potential (PBP), 
striatum binding potential (SBP) and putamen-to-caudate ratio (PCR)) along with 
dimensional features related to the volume, width, length, and thickness. The automated 
computation of the uptake ratios was based on the counts inside the volumetric ROIs placed 
Figure 3.3 | Example of caudate and putamen 3D ROIs visualization: 
on the left, an axial plane; middle top, a coronal plane; middle bottom, a 
sagittal plane, and on the right, the scale represents the number of counts 
per voxel. 
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over the registered image under study. The BPND referred to the ratio at equilibrium of 
specifically bound radioligands to the non-displaceable ones in tissue, and it encompassed 
three regions: the CBP, the PBP and the SBP.  
BPND was given by BPND = (VT - VND) / VND, where VT was the radioligands volume of 
distribution of the target region and VND was the sum of the volume of distribution of the free 
and non-specifically bound ligand. Since VT and VND were directly proportional to the counts 
per voxel of the target and reference regions, respectively, then CBP = (C - R) / R, PBP = (P 
- R) / R, and SBP = (S - R) / R, where C was the mean count per voxel in the caudate ROI, 
R was the mean count per voxel within the reference region, P was the mean count per 
voxel in the putamen ROI and S was the mean count per voxel in the striatum (caudate and 
putamen ROIs). The PCR was also computed and it was given by PCR = PBP/CBP.  
The literature suggested the binding potential could be defined at the voxel level as 
BPND = [ I(x,y,z) – R] / R, where I (x,y,z) was the count associated to the voxel with 
coordinates (x,y,z), and R was the mean count per voxel within the reference ROI [40]. The 
Figure 3.4 shows an example of a BPND image built.  
 
 
The extraction of the region with uptake was performed on the BPND image, and it was based 
on a cut-off level, which means that only voxels with a BPND higher than the cut-off level 
defined were included in the segmented region. After the initial cut-off, the binary image 
obtained was cleaned of scattered voxels by selecting only the larger group of connected 
voxels in each hemisphere. The total volume of the two sides of the segmented striatal 
region and the corresponding lengths were automatically calculated from the segmented 
image based on the orientation established for the template image as illustrated in the 
Figure 3.4 | Example of a BPND image built from a subject without 
denervation: On the left, an axial slice is visible; middle top, a coronal slice; 
middle bottom, a sagittal slice; and on the right, the dimensionless BPND colour 
scale used (only voxels with a positive BPND are shown). 
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Figure 3.5. When there were no voxels with BPND greater than the cut-off level defined, the 
dimensional features were set to zero.  
The optimal cut-off level was chosen based on the classification accuracy, i.e. the 
cut-off value that originated the best discrimination between without denervation and with 
denervation patients using the volume and length dimensional measures was chosen. 
 
 
 
 
 
 
 
 
 
 
 
3.3 Procedures 
The procedures included:  
i. Assembling the equipment for data collection;  
ii. The Injection: all participants were first injected with 123Ioflupane. After that, the 
participants were approached and it was explained what our study consisted of. 
Then they were invited to participate; 
iii. The individuals, who accepted to participate, signed the consent form at the 
nuclear medicine unit at the same place where they had been injected (CCC), 
being then headed for a corridor that was used for the assessment (with two red 
marks on the floor indicating the start and the end of the meters that the 
participants had to walk);  
iv. MDS-UPRDS-III scale evaluation;  
v. Equipping the participants with the inertial sensors (with dimensions of 
47x30x13mm and a sampling rate of 1000Hz); 
vi. The sensors were synchronized (time-synchronization ≤10 µs), and calibrated 
before starting collecting; 
vii. The next step was to instruct the participants to stay still in orthostatic position, 
first with the feet as close together as possible and then with both feet shoulder-
width apart, for postural control acquisition. The arms persisted motionless along 
the body and eyes fixed at a point ahead. The participants were instructed to 
Figure 3.5| Example of the segmented region with 
normal uptake obtained from a subject without 
denervation. The arrows indicate the directions 
defined for measuring the length.   
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keep their posture for one acquisition of 30s each with eyes open. The 
participants performed three walking trials for kinematics gait acquisition, in a 
straight line along a 15m x2 long walkway without any assistance; 
viii. Unequipping the participants and taking them back to nuclear medicine unit; 
ix. 123I-FP-CIT SPECT (DATScanTM): Dopamine Transporter (DAT) imaging was 
assessed through DATScan performed at the Nuclear Medicine Unit in CCC. 
SPECT scans lasted from 30 to 45 min and they started post-injection of activity 
between 110 and 185 MBq.  
x. Disassembling the equipment for data collection.  
 
3.4 Statistical Analysis 
The Statistical analysis was performed using IBM Statistical Package for the Social Sciences 
(SPSS Statistics) Version 22.0. The data analysis presented was carried out in demographic  
data that were assumed as independent observations and they were tested with the t-test 
because they were continuous variables.  
Secondly, it was compared the means of the lowest specific binding ratio (SBR) of 
denervated individuals with the highest SBR of non-denervated individuals because an 
individual with denervation is not equal in the both sides, thus avoiding having inflated 
values. There is one side that is worse than the other one. However, a person can have a 
good side, i.e., a normal one. It was also compared the best brain sides, as well as the 
asymmetries indexes of the DAT-Scan variables, through the independent t-tests to 
determine whether there was a statistically significant difference between the means in the 
two groups (the patients with and without denervation). The same procedure was applied to 
the kinematics data. It was established a significance level of 0.05. 
It was also made a Pearson correlation to determine associations just for the group 
of individuals with denervation between the 123I-FP-CIT SPECT (DAT-Scan) and the 
kinematic variables, and between the MDS-UPDRS III and the kinematic variables. The 
reliability of the joint angles was determined based on the correlation coefficient (r), including 
the 95% confidence interval. The correlations were classified as very strong (0.9-1.0), strong 
(0.7-0.9), moderate (0.5-0.69), weak (0.3-0.49) and negligible (<0.30) based on [76].  
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4 Results 
The aim of this work is to discover if kinematics can give the same information as the DAT-
Scan. It will be made a description of the main outcomes from clinical and demographic data 
to the associations between DAT-Scan, kinematics and MDS-UPDRS III (motor symptoms), 
throughout this chapter.  
 
4.1 MDS-UPDRS III subscores  
Twenty-one patients participated in this study, being recruited from the Nuclear Medicine 
Unit in the Champalimaud Clinical Centre (CCC), Lisbon. Within these 21 patients, 10 of 
them had denervation (mean age, 68.4 ± 7.8 years) and the remaining 11 (mean age, 66.6 ± 
7.4 years) did not present denervation.   
According to what was described in section 2.1.3, the Movement Disorder 
Society‐Unified Parkinson Disease Rating Scale (MDS‐UPDRS III) was subdivided into 4 
subscores: tremor, rigidity, bradykinesia and axial. The demographic and clinical 
characteristics of all study participants are displayed in the Table 4.1.  
Table 4.1: Demographic and clinical characteristics of all participants. 
 
Individuals with 
denervation  
(n = 10) 
Individuals without 
denervation                                               
(n = 11) 
p -value 
Male 3 4  
Female 7 7  
 Mean ± Std Mean ± Std  
Age (years) 68.4 ± 7.8 66.6 ± 7.4 0.809a 
LED (mg) 273.0 ± 313.0 139.5 ± 214.9 0.057a 
Total MDS-UPDRS 
III score 
29.0 ± 16.2 15.3 ± 10.3 0.072a 
Sum of axial 
subscore 
7.6 ± 3.7 4.0 ± 3.6 0.045*a 
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4.2 Distinction between normal and abnormal from 
DAT-Scan  
As it was explained in chapter 2, it was given a normal interpretation regarding to DAT-Scan 
if there was a homogeneous symmetrical comma type pattern in the striatum (normal DAT-
Scan – individual without denervation). Another pattern was interpreted as abnormal, 
indicating a PS (abnormal DAT-Scan – individual with denervation). An illustrative DAT-Scan 
is shown in Figure 4.1: normal (A) and abnormal (B).  
 
 
 
 
 
 
 
 
 
 
 
Sum of 
bradykinesia 
subscore 
4.4 ± 4.4 2.1 ± 1.9 0.052a 
Sum of rigidity 
subscore 
13.2 ± 4.1 6.8 ± 3.4 0.034*a 
Sum of tremor 
subscore 
5.0 ± 1.4 3.1 ± 1.9 0.047*a 
Duration of Motor 
Symptoms 
(months) 
85.8 ± 80.9 29.2 ± 11.7 0.017*a 
Abbreviations:  
Clinical features: LED Levodopa Equivalent Dose, MDS UPDRS Movement Disorder Society 
Unified Parkinson’s Disease Rating Scale. 
Others: Std Standard Deviation, n sample size. 
Data are expressed as mean ± standard deviation.  
a= t test (p <0.05 - *Statistically significant difference).  
 
Figure 4.1| Representative DAT-Scan: (A) normal - the striatum has a comma shape; (B) abnormal – the 
striatum has not a comma pattern.  
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For each patient the specific binding ratio (SBR) was compared and sides were grouped 
based on lower SBR (more denervation) of high SBR (less denervation). It was also 
compared the asymmetries indexes in order to observe differences between a normal DAT-
Scan (individuals without denervation) comparatively to abnormal DAT-Scan (individuals with 
denervation).  
 
The comparative analysis between the lower SBR sides of abnormal and normal 123I-
FP-CIT SPECT (DAT-Scan) are presented in Table 4.2. The values statistically significant 
are in bolt. The results showed that the lower SBR side values of uptake ratio-based features 
and dimensional features related to the volume, width, length, and thickness in individuals 
with dopamine depletion in the striatum (abnormal DAT-Scan) are inferior regarding to the 
lower SBR side in individuals without dopamine depletion. 
 
Table 4.2: Clinical data of the lower SBR sides of an abnormal and a normal DAT-Scan. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Abnormal DAT-Scan / 
Individual with 
denervation (n = 10) 
Normal DAT-Scan / 
Individual without 
denervation (n = 11) 
p-value 
            (Mean ± Std)    (Mean ± Std)  
SBR (a.u.) 2.99 ± 0.07 4.58 ± 1.13 0.004*a 
CBP (a.u.) 1.39 ± 0.03 1.99 ± 0.32 <0.001a 
PBP (a.u.) 0.68 ± 0.04 1.46 ± 0.29 <0.001
a 
SBP (a.u.) 1.02 ± 0.05 1.72 ± 0.29 <0.001a 
PCR (a.u.) 0.49 ± 0.08 1.71 ± 0.09 0.003*
a 
Volume (mm3) 1763.75 ± 780.18 6892.72 ± 3074.97 0.001*a 
Width (mm) 11.33 ± 0.52 19.15 ± 2.92 0.001*a 
Length (mm) 11.80 ± 0.36 32.17 ± 4.63 0.001*a 
Thickness (mm) 13.52 ± 0.04 22.81 ± 3.16 0.009*a 
Abbreviations:  
Uptake ratio features: SBR Specific Binding Ratio, CBP Caudate Binding Potential, PBP 
Putamen Binding Potential, SBP Striatum Binding Potential, PCR Putamen to Caudate Ratio. 
Others: a.u. arbitrary units, n sample size. 
Data are expressed as mean ± standard deviation. 
a=t test: lower SBR sides of abnormal vs. normal DAT-Scan (p <0.05 - *Statistically significant 
difference).  
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The means and respective standard deviations of each side of the brain, as well as the 
comparative analysis between the high SBR sides of these two groups can be seen in 
Appendix 3 (Table 8.3 and Table 8.4), respectively.   
 
The comparative analysis between the asymmetry indexes of the abnormal and the 
normal DAT-Scan are presented in Table 4.3. The values statistically significant are in bold. 
The results showed that the asymmetry indexes in the abnormal DAT-Scan are higher than 
in the normal DAT-Scan. Significant differences are also identified between the groups in all 
features. 
 
Table 4.3: Clinical data of asymmetry indexes between normal and abnormal DAT-Scan. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abnormal/With 
denervation (n = 10) 
Normal/Without 
denervation (n = 11) 
 
 Asymmetry index 
 (Mean ± Std) 
Asymmetry index 
 (Mean ± Std) 
p-value 
SBR (a.u.) 0.35 ± 0.10 0.01 ± 0.03 0.002*a 
CBP (a.u.) 0.18 ± 0.69 0.03 ± 0.04 <0.001a 
PBP (a.u.) 0.33 ± 0.19 0.28 ± 0.09 <0.001a 
SBP (a.u.) 0.17 ± 0.40 0.04 ± 0.66 <0.001a 
PCR (a.u.) 2.23 ± 1.11 2.25 ± 1.30 <0.001a 
Volume (mm3) 0.57 ± 0.23 0.06 ± 0.02 0.001*a 
Width (mm) 2.15 ± 1.23 0.10 ± 0.06 0.001*a 
Length (mm) 2.23 ± 1.54 2.08 ± 0.45 <0.001a 
Thickness (mm) 1.92 ± 0.21 0.27 ± 0.66 0.008*a 
Abbreviations:  
Uptake ratio features: SBR Specific Binding Ratio, CBP Caudate Binding Potential, PBP 
Putamen Binding Potential, SBP Striatum Binding Potential, PCR Putamen to Caudate Ratio. 
Others: a.u. arbitrary units, n sample size. 
Data are expressed as mean ± standard deviation. 
a=t test: asymmetry indexes of abnormal vs. normal DAT-Scan (p <0.05 - *Statistically 
significant difference).  
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4.3 Distinction between normal and abnormal from 
Kinematics  
As referred in section 3.2 the kinematics results were based on the extracted spatiotemporal 
features. The following table (Table 4.4) presented display the mean values of the 
kinematics data collected statistically, based on denervated and non-denervated individuals.  
 
Table 4.4: Statically summary of the gait spatiotemporal parameters.  
 
Individual with denervation 
(n = 10)  
(Mean ± Std) 
Individual without 
denervation (n = 11) 
 (Mean ± Std) 
Cycle duration (s) 
1.14 ± 0.15 1.14 ± 0.16 
Support phase dur (%) 68.35 ± 12.93 67.31 ± 12.27 
Swing phase dur (%) 31.65 ± 2.93 32.69 ± 2.27 
Cadence (steps/min) 108.2 ± 12.78 106.7 ± 16.00 
Step duration (s) 0.57 ± 0.07 0.56 ± 0.05 
Step duration as (%) 1.63 ± 1.53 1.68 ± 1.46 
Step length (cm) 45.32 ± 11.72 48.60 ± 9.33 
Step length as (cm) 3.74 ± 3.43 3.66 ± 2.54 
Step height (cm) 3.97 ± 2.59 5.10 ± 2.09 
Step width (cm) 14.79 ± 5.21 11.18 ± 6.41 
Gait speed (m/s)  0.84 ± 0.30 0.88 ± 0.12 
Double support ph (%) 18.35 ± 3.21 16.33 ± 2.60 
Arm swing (cm) 39.79 ± 20.42 43.83 ± 18.20 
Abbreviations:  
Kinematics variables: Support phase dur Support phase duration, Swing phase dur Swing phase 
duration, Step duration as Step duration asymmetry, Step length as Step length asymmetry, 
Double support ph Double support phase.  
Others: n sample size. 
Data are expressed as mean ± standard deviation. 
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In agreement with the worst side of DAT-Scan (lower SBR in the striatum), there is 
also the worst side of the body. This association manifests on opposite sides, i.e., if the 
affected side of the brain is the right side, then these changes will be visible on the left side 
of the body and vice versa. Here the worst side is defined by a decrease in the support and 
the swing phase duration. It is also set by a step duration, length, and height, as well as an 
arm swing reduced.  
The Table 4.5 presents a comparative analysis between the worst sides of the 
bilateral variables of the denervated and non-denervated individuals. It shows that the worst 
side of the denervated individuals is not different from the worst side of the non-denervated 
individuals, once no significant differences were found in none of the parameters observed.  
 
Table 4.5: Kinematics data of the Worst side of the body in individuals with and without denervation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The means and respective standard deviations on either body’s side (left and right) of the 
collected biomechanical parameters, as well as the comparative analysis between the best 
sides of the body between these two groups can be seen in Appendix 4 (Table 8.5 and 
Table 8.6), respectively.   
 
The following table (Table 4.6) shows that regarding to the asymmetry indexes no 
significant differences were found between the individuals with denervation and the 
individuals without denervation.  
 
 Individual with 
denervation (n = 10) 
(Mean ± Std) 
Individual without 
denervation (n = 11) 
(Mean ± Std) 
p-value 
Support phase dur (%) 
68.39 ± 2.80 68.20 ± 1.67 0.591
a 
Swing phase dur (%) 31.61 ± 2.80 31.80 ± 2.65 0.591a 
Step duration (s) 0.57 ± 0.07 0.58 ± 0.05 0.694
a 
Step length (cm) 42.78 ± 12.09 46.46 ± 4.92    0.616a 
Step height (cm) 3.36 ± 2.81 4.57 ± 2.09 0.363
a 
Arm swing (cm) 36.00 ± 16.83 43.32 ± 12.29 0.539a 
Abbreviations:  
Kinematics variables: Support phase dur Support phase duration, Swing phase dur Swing 
phase duration. 
Others: n sample size. 
Data are expressed as mean ± standard deviation. 
a=t test: worst side of individuals with denervation vs. individuals without denervation, (p <0.05 - 
*Statistically significant difference). 
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Table 4.6: kinematics comparison of asymmetry indexes between individuals with and without 
denervation. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Individuals with 
denervation (n = 10) 
Individuals without 
denervation (n = 11) 
 
 Asymmetry index 
 (Mean ± Std) 
Asymmetry index 
 (Mean ± Std) 
p-value 
Support phase dur (%) 0.57 ± 0.39 1.01 ± 0.66 0.064a 
Swing phase dur (%) 0.88 ± 0.69 0.71 ± 0.57 0.698a 
Step duration (s) 1.55 ± 0.07 0.16 ± 0.05 0.041*a 
Step length (cm) 0.51 ± 0.27 0.10 ± 0.33    0.888a 
Step height (cm) 0.74 ± 0.59 0.90 ± 0.66    0.397a 
Arm swing (cm) 0.69 ± 0.25 0.50 ± 0.26 0.647a 
Abbreviations:  
Kinematics variables: Support phase dur Support phase duration, Swing phase dur Swing 
phase duration. 
Others: n sample size. 
Data are expressed as mean ± standard deviation. 
a = t test: Asymmetry indexes between individuals with and without denervation, (p <0.05 - 
*Statistically significant difference). 
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4.4 Patients with Denervation 
As it was observed, in kinematics there are no significant differences between the worst and 
best sides, as well as in the asymmetries between the individuals with and without 
dopaminergic depletion. So, it was performed an exploratory analysis in the individuals who 
presented denervation.  
 
4.4.1 Correlation between DAT-Scan and Kinematics 
To determine the intensity of the relationship between the DAT-Scan and the 
kinematics, it was made a Pearson correlation between these two groups. This correlation 
analysis was performed in the two hemispheres of the brain with the two sides of the body, 
i.e., the right hemisphere (DAT-Scan R) with the left part of the body (Kinematics L) vs. the 
left hemisphere (DAT-Scan L) with the right part of the body (Kinematics R). The Table 4.7 
shows the strength of the relationship between the DAT-Scan and the kinematics, which is 
indicated by the correlation coefficient (r), and it also shows the significance of this 
relationship that is expressed in probability levels, through the p-value (p). The significance 
in a correlation is greater the larger the difference between the sample, that is, the more the 
sample statistic deviates from the population parameter. 
Overall, the results demonstrated that the variables have negligible statistically 
significant differences. The scatterplots of these correlations are presented in Appendix 5 
(Figures8(A)-(I)). 
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Table 4.7: Correlation matrix of DAT-Scan (R) + kinematic (L) and DAT-Scan (L) + kinematic (R). 1st row/column: SBR (a.u) vs Support phase duration (%); 2nd row/column: 
CBP (a.u) vs Swing phase duration (%); 3rd row/column: PBP (a.u.) vs Step duration (s) and so on.  
 
SBR (a.u.) CBP (a.u.) PBP (a.u.) SBP (a.u.) PCR (a.u.) Volume (  Width (  Length (  Thickness (  
Support phase duration (%) 
r 0.042 0.163 -0.113 0.135 -0.161 0.104 0.051 0.049 0.090 
p 0.804 0.990 0.385 0.727 0.230 0.775 0.848 0.955 0.938 
Swing phase duration (%) 
r    -0.135 -0.163 0.113 -0.127 0.161 -0.088 -0.051 -0.049 -0.028 
p 0.804 0.990 0.385 0.727 0.230 0.775 0.848 0.955 0.938 
Step duration (s) 
r 0.000 0.044 -0.218 0.171 -0.236 0.072 0.085 0.052 0.192 
p 1.000 0.903 0.545 0.742 0.512 0.555 0.793 0.886 0.970 
Step length (cm) 
r 0.063 0.092 0.243 0.160 0.181 0.209 0.146 0.118 0.066 
p 0.863 0.801 0.499 0.658 0.618 0.562 0.686 0.745 0.856 
Step height (cm) 
r -0.375 -0.182 0.259 -0.006 0.566 -0.117 -0.029 -0.056 -0.097 
p 0.461 0.614 0.469 0.986 0.088 0.748 0.937 0.878 0.790 
Arm swing (cm) 
r -0.455 -0.368 -0.087 -0.272 0.276 -0.104 -0.339 -0.259 -0.318 
p 0.223 0.296 0.811 0.446 0.440 0.775 0.461 0.470 0.370 
Abbreviations:  
Uptake ratio features: SBR Specific Binding Ratio, CBP Caudate Binding Potential, PBP Putamen Binding Potential, SBP Striatum Binding Potential, PCR Putamen to Caudate 
Ratio. Others: r Pearson Correlation, p p-value, a.u. arbitrary units. * Statistically significant difference 
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4.4.2 Correlation between Kinematics and MDS-UPDRS III 
The correlation analysis shown in Table 4.8 was performed in the kinematics and MDS-
UPDRS III. According to this analysis, UPDRS motor scores revealed a significant negative 
correlation with (A) swing phase duration (r  -0.781, p  0.041), (B) step length (r  -0.832, 
p  0.003) and (C) gait speed (r  -0.849, p  0.002, Figure 4.2). This means that the 
higher motor symptoms are, the more time is the swing phase duration and the step length, 
and the worse is the gait speed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2| Scatterplot of kinematic variables with a significant negative correlation for 
individuals with denervation: (A) Swing phase duration (%) vs MDS-UPDRS III; (B) Step length 
(cm) vs MDS-UPDRS III; (C) Gait speed (m/s) vs MDS-UPDRS III. 
Step length vs. MDS- UPDRS III 
UPDRS III 
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The results also showed that cadence has a negative moderate correlation with UPDRS motor scores (r  -0.651, p  0.014), and cycle duration (r  0.638, p 
 0.047),  support phase duration (r  0.714, p  0.014),  double support phase (r  0.734, p  0.016) and double support phase.1 (r  0.645, p  0.044)  
showed a positive moderate correlation with UPDRS motor scores. That means that the more severe are the motor symptoms, the higher is the support phase 
duration, the more is the double support phase and the double support phase.1.  
 
Table 4.8: Correlation matrix of MDS-UPDRS III and biomechanical parameters. 1st row/column: cycle duration vs MDS-UPDRS III; 2nd row/column: Support phase duration vs 
MDS-UPDRS III; 3rd row/column: swing phase duration vs MDS-UPDRS III; (…) 14th row/column: Arm swing vs MDS-UPDRS III. 
 
 
Individuals with denervation (n=10) 
Correlation 
coefficient  
Cycle 
duration 
(s) 
Support 
pha dur 
(%) 
Swing 
pha dur 
(%) 
Cadence 
(steps/min) 
Step 
duration 
(s) 
Step 
DAs 
(%) 
Step 
Length 
(cm) 
Step 
LAs 
(%) 
Step 
height 
(cm) 
Step 
width 
(cm) 
Gait 
speed 
(m/s) 
Double 
support 
ph (%) 
Double 
supp 
ph1(%)  
Arm 
swing 
(cm) 
MDS-
UPDRS III 
 
r 
 
0.638* 
 
0.714* 
-0.781** -0.651* 
 
0.534 
-0.101 
-
0.832** 
 
0.590 
-0.374 
 
0.356 
-
0.849** 
 
0.734* 
 
0.645* 
-0.509 
p 0.047* 0.014* 0.008* 0.041* 0.112 0.781 0.003* 0.072 0.287 0.312 0.002* 0.016* 0.044* 0.133* 
Abbreviations: 
 Kinematics variables: Support pha dur Support phase duration, Swing pha dur Swing phase duration, Step DAs Step duration asymmetry, Step LAs Step length asymmetry, 
Double support ph Double support phase, Double supp ph1 Double support phase 1. 
Others: n sample size.  
r Pearson Correlation, p p-value.  
*Statistically significant difference (p <0.05). 
* Correlation is significant at level 0.05 
** Correlation is significant at level 0.01 
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5 Discussion  
It was investigated, in this study, the role of the inertial sensors in distinguishing between the 
denervated and the non-denervated individuals. When we defined "clinically" denervation, 
quantitatively we had results in line with this. The results presented in the section 4.1 
confirmed that the DAT-Scan could distinguish these two groups because significant 
differences were found between the lowest specific binding ratio (SBR) and the highest SBR 
(appendix 3) sides of the striatum in both the denervated and the non-denervated 
individuals. Significant differences were also found in the asymmetry indexes, of the 
striatum, between these two groups. However, according to the results presented in the 
section 4.2, the classic spatiotemporal kinematics measures could not distinguish between 
the denervated and the non-denervated individuals. 
Interestingly, we found that kinematics was highly correlated with the classic clinical 
motor assessment (MDS-UPDRS III) in the patients presenting dopaminergic denervation 
(independently of the diagnosis) we’ve found that kinematics was highly correlated with the 
classic clinical motor assessment (MDS-UPDRS III). This means that, in non-healthy 
individuals, the full body kinematics (FBK) metrics capture dimension that have been defined 
by the neurological community as relevant in the assessment of Parkinsonian conditions. 
Therefore, FBK can have a role in human movement assessment.  
It wasn´t found any correlation by the comparison between kinematics metrics and 
the DAT-Scan quantitative results. This may lead to the hypothesis that a non-linear 
relationship between motor impairment and dopaminergic denervation exist across 
Parkinsonian disorders.  
The fact that these results are not showing this relationship can have several 
explanations: the DAT-Scan is very noisy and it does not measure the dopamine (DA), 
instead of that it measures the availability of the presynaptic dopamine transporters (DATs). 
This can be overcome by the fluorodopa - F-DOPA, a fluorinated form of levodopa -L-DOPA 
for use as a radiotracer. In fact, it is known that the motor symptoms in the PD only start after 
the striatal denervation reaches 70%. Besides this, there are compensation systems in the 
brain whereby the progression can be nonlinear. At the same time, patients are having 
symptomatic drugs. These are some of the factors that may have influenced our results.  
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The results also showed that there was a considerable asymmetry on the upper 
limbs in both denervated and non-denervated individuals. What make us think that these 
kinematic variables should be better explored.  
Our study has some limitations that must be considered, such as the small sample 
size. There are also many variables. However, we included individuals whose diagnosis is 
unknown. 
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6 Conclusions and Future Perspectives 
Walking is fundamental to everyday functioning and independence, and the Parkinson’s 
disease (PD) affects particularly this ability. A better understanding of the reasons and ways 
can provide information that may be helpful for future research on the motor (MS) and non-
motor (NMS) symptoms of the PD that can cause impact in the gait. Moreover, the 
quantitative measurements of the gait parameters have become available in the clinic, 
thanks to the reduced size and the low-cost technologies (e.g. inertial sensors). 
As main topic, the role of inertial sensors in distinguishing between the denervated 
and the non-denervated individuals, has been investigated in this dissertation. The main 
finding is that no differences were found in the classic kinematics metrics between the two 
groups (the denervated and the non-denervated individuals). However, the kinematics 
correlated with what the clinician saw in the patients, but it did not correlate strongly with the 
DAT-Scan. The kinematics took the metrics form the movement, which were considered 
relevant by the clinicians, but it did not relate linearly to the DAT-Scan results.  
These results made us think that it may exist other extractable variables that allow 
us to distinguish between these two groups, such as the olfactory system variable. Thus, 
future research should focus on nonlinear metrics to detect denervation in the early stages of 
Parkinson’s disease.  
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8 Appendices 
8.1 Appendix 1  
Table 8.1: List of the equipment used in this dissertation work. 
Name Company 
15x MTw Awinda Wireless 3DOF Motion Tracker  Xsens 
15x Velcro Full Body Straps Set  
1x Awinda Recording and Docking Station 
1x Awinda Receiving Dongle 
1x MTw Software Development Kit 
 
 
 
 
8.2  Appendix 2 
Table 8.2: List of the software used in this dissertation work. 
Name Company Version 
ITK-SNAP https: //www.itksnap.org 3.8.0 
Link   
Kinetikos https://www.platform.kinetikos.io 2016-19 
Python language   
Excel   
SPSS Statistics  22.0 
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8.3 Appendix 3 
 
 Table 8.3: Mean of clinical characteristics of the striatum. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abnormal /With denervation 
(n = 10) 
Normal /Without denervation 
(n = 11) 
Right (Mean ± 
Std) 
Left (Mean 
± Std) 
Right (Mean ± 
Std) 
Left (Mean ± 
Std) 
SBR (a.u.) 3.10 ± 0.06 3.01 ± 0.06 4.77 ± 0.15 4.57 ± 0.15 
CBP (a.u.) 1.26 ± 0.04 1.28 ± 0.04 2.06 ± 0.16 2.00 ± 0.16 
PBP (a.u.) 0.71 ± 0.05 0.67 ± 0.05 1.51 ± 0.15 1.48 ± 0.15 
SBP (a.u.) 0.96 ± 0.04 0.95 ± 0.04 1.76 ± 0.15 1.72 ± 0.15 
PCR (a.u.) 0.54 ± 0.10 0.54 ± 0.10 0.74 ± 0.11 0.74 ± 0.11 
Volume 
(mm3) 
1.45 ± 0.15 1.15 ± 0.15 7.31 ± 0.58 6.49 ± 0.58 
Width 
(mm) 
9.42 ± 0.07 10.24 ± 
0.07 
20.20 ± 0.19 19.54 ± 0.19 
Length 
(mm) 
10.41 ± 0.06 11.59 ± 
0.06 
33.28 ± 0.22 32.97 ± 0.22 
Thickness 
(mm) 
12.55 ± 0.09 12.72 ± 
0.09 
24.34 ± 0.21 23.28 ± 0.21 
Abbreviations:  
Uptake ratio features: SBR Specific Binding Ratio, CBP Caudate Binding Potential, PBP 
Putamen Binding Potential, SBP Striatum Binding Potential, PCR Putamen to Caudate 
Ratio. 
Others: n sample size, Std standard deviation, a.u. arbitrary units.   
Data are expressed as mean ± standard deviation. 
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Table 8.4: Clinical data of the high SBR sides of an abnormal and a normal DAT-Scan 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Abnormal DAT-Scan / 
Individual with 
denervation (n = 10) 
(Mean ± Std) 
Normal DAT-Scan / 
Individual without 
denervation (n = 11) 
(Mean ± Std) 
p-value 
SBR (a.u.) 3.28. ± 0.94 4.77 ± 1.23  0.035*a 
CBP (a.u.) 1.64 ± 0.27 2.07 ± 0.31    0.043*a 
PBP (a.u.) 0.79 ± 0.26 1.53 ± 0.28   <0.001*a 
SBP (a.u.) 1.18 ± 0.24 1.77 ± 0.29   0.009*a 
PCR (a.u.) 0.54 ± 0.05 0.76 ± 0.07 <0.001*a 
Volume (mm3) 2848.00 ± 0.35 7759.08 ± 2897.60 0.001*a 
Width (mm) 14.28 ± 0.40 20.58 ± 3.28 0.035*a 
Length (mm) 15.04 ± 0.92 34.08 ± 4.61 <0.001*a 
Thickness (mm) 16.97 ± 0.37 24.81 ± 3.88 0.009*a 
Abbreviations:  
Uptake ratio features: SBR Specific Binding Ratio, CBP Caudate Binding Potential, PBP 
Putamen Binding Potential, SBP Striatum Binding Potential, PCR Putamen to Caudate Ratio. 
Others: a.u. arbitrary units, n sample size. 
Data are expressed as mean ± standard deviation. 
a=t test: High SBR side of abnormal vs. normal DaTScan (p <0.05- *Statistically significant 
difference).  
 
Inertial sensor based full body 3D kinematics in the differential diagnosis between 
Parkinson’s Disease and mimics 
___________________________________________________________________ 
52 
 
 
8.4 Appendix 4 
 Table 8.5: Mean of bilateral gait metrics. 
 
 
 
 
 
Abnormal/ With denervation  
(n = 10) 
Normal /Without denervation 
 (n = 11) 
Right (Mean ± 
Std) 
Left (Mean ± 
Std) 
Right (Mean ± 
Std) 
Left (Mean ± 
Std) 
Cycle duration  1.14 ± 0.10 1.16 ± 0.06 
Support phase dur 
 
67.83 ± 2.67 68.95 ± 2.02 68.52 ± 1.69 66.92 ± 2.60 
Swing phase dur 
 
32.17 ± 2.67 31.05 ± 2.02 31.48 ± 1.69 33.08 ± 2.60 
Cadence 
 
108.29 ± 8.79 104..09 ± 4.54 
Step duration  0.58 ± 0.06 0.55 ± 0.05 0.58 ± 0.04 0.58 ± 0.04 
Step duration as 
 
1.78 ± 0.11 1.21 ± 0.90 
Step length  45.92 ± 7.36 43.87 ± 10.83 48.62 ± 4.22 46.52 ± 5.42 
Step length as  3.74 ± 2.49 5.66 ± 3.46 
Step height  4.31 ± 2.15 4.14 ± 2.51 4.61 ± 1.43 4.66 ± 2.29 
Step width  15.08 ± 3.41 11.91 ± 5.36 
Gait speed  0.83 ± 0.23 0.84 ± 0.11 
Double support ph 
 
18.41 ± 2.08 17.01 ± 2.10 
Double support ph1 
 
18.38 ± 2.91 18.75 ± 2.05 
Arm swing (c  37.33 ± 11.93 46.36 ± 21.36 40.85 ± 12.72 43.79 ± 14.54 
Abbreviations:  
Gait metrics: Support phase dur Support phase duration, Swing phase dur Swing phase duration, Step 
duration as Step duration asymmetry, Step length as Step length asymmetry, Double support ph 
Double support phase, Double support ph1 Double support phase 1. 
Others: n sample size. 
Data are expressed as mean ± standard deviation. 
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Table 8.6: Kinematics data of the Best side of the body in individuals with and without denervation.  
  Individual with 
denervation (n = 10) 
(Mean ± Std) 
Individual without 
denervation (n = 11) 
(Mean ± Std) 
p-value 
Support phase dur (%) 
69.12 ± 2.67 68.73 ± 1.79 0.385a 
Swing phase dur (%) 32.34 ± 2.99 33.29 ± 2.44    0.418a 
Step duration (s) 0.58 ± 0.08 0.59 ± 0.03 0.341a 
Step length (cm) 44.90 ± 11.17 44.48 ± 4.22 0.260a 
Step height (cm) 4.23 ± 2.47 3.79 ± 1.79 0.170a 
Arm swing (cm) 41.93 ± 19.47 46.03 ± 11.79 0.748a 
Abbreviations:  
Kinematics variables: Support phase dur Support phase duration, Swing phase dur Swing 
phase duration. 
Others: n sample size. 
Data are expressed as mean ± standard deviation. 
a =t test: worst side vs. best side of individuals with denervation, (p <0.05 - *Statistically 
significant difference). 
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8.5 Appendix 5 
 
 
 
Figure 8.1| A) Scatterplots of correlations of data gathered from the inertial sensors and Specific 
Binding Ratio - SBR (a.u.) of individuals with denervation. On left top corner, Correlation between 
support phase duration (%) and SBR; on right top corner, Correlation between swing phase duration (%) 
and SBR; on middle left, Correlation between step duration (s) and SBR; on middle right, Correlation 
between step length (cm) and SBR; on left bottom corner, Correlation between step height (cm) and 
SBR, and on right bottom corner, Correlation between arm swing (cm) and SBR. 
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Figure 8.2| B) Scatterplots of correlations of data gathered from the inertial sensors and 
Caudate Binding Potential - CBP (a.u.) of individuals with denervation. On left top corner, 
Correlation between support phase duration (%) and CBP; on right top corner, Correlation between 
swing phase duration (%) and CBP; on middle left, Correlation between step duration (s) and CBP; 
on middle right, Correlation between step length (cm) and CBP; on left bottom corner, Correlation 
between step height (cm) and CBP, and on right bottom corner, Correlation between arm swing 
(cm) and CBP. 
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Figure 8.3| C) Scatterplots of correlations of data gathered from the inertial sensors and 
Putamen Binding Potential - PBP (a.u.) of individuals with denervation. On left top corner, 
Correlation between support phase duration (%) and PBP; on right top corner, Correlation between 
swing phase duration (%) and PBP; on middle left, Correlation between step duration (s) and PBP; on 
middle right, Correlation between step length (cm) and PBP; on left bottom corner, Correlation 
between step height (cm) and PBP, and on right bottom corner, Correlation between arm swing (cm) 
and PBP. 
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Figure 8.4| D) Scatterplots of correlations of data gathered from the inertial sensors and Striatum 
Binding Potential - SBP (a.u.) of individuals with denervation. On left top corner, Correlation between 
support phase duration (%) and SBP; on right top corner, Correlation between swing phase duration (%) 
and SBP; on middle left, Correlation between step duration (s) and SBP; on middle right, Correlation 
between step length (cm) and SBP; on left bottom corner, Correlation between step height (cm) and SBP, 
and on right bottom corner, Correlation between arm swing (cm) and SBP. 
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Figure 8.5 | E) Scatterplots of correlations of data gathered from the inertial sensors and 
Putamen to Caudate Ratio - PCR (a.u.) of individuals with denervation. On left top corner, 
Correlation between support phase duration (%) and PCR; on right top corner, Correlation between 
swing phase duration (%) and PCR; on middle left, Correlation between step duration (s) and PCR; 
on middle right, Correlation between step length (cm) and PCR; on left bottom corner, Correlation 
between step height (cm) and PCR, and on right bottom corner, Correlation between arm swing 
(cm) and PCR. 
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Figure 8.6| F) Scatterplots of correlations of data gathered from the inertial sensors and 
volume (mm3) of individuals with denervation. On left top corner, Correlation between support 
phase duration (%) and volume; on right top corner, Correlation between swing phase duration (%) 
and volume; on middle left, Correlation between step duration (s) and volume; on middle right, 
Correlation between step length (cm) and volume; on left bottom corner, Correlation between step 
height (cm) and volume, and on right bottom corner, Correlation between arm swing (cm) and 
volume. 
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Figure 8.7| G) Scatterplots of correlations of data gathered from the inertial sensors and width 
(mm) of individuals with denervation: On left top corner, Correlation between support phase 
duration (%) and width; on right top corner, Correlation between swing phase duration (%) and 
width; on middle left, Correlation between step duration (s) and width; on middle right, Correlation 
between step length (cm) and width; on left bottom corner, Correlation between step height (cm) 
and width, and on right bottom corner, Correlation between arm swing (cm) and width. 
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Figure 8.8| H) Scatterplots of correlations of data gathered from the inertial sensors and 
length (mm) of individuals with denervation: On left top corner, Correlation between support 
phase duration (%) and length; on right top corner, Correlation between swing phase duration (%) 
and length; on middle left, Correlation between step duration (s) and length; on middle right, 
Correlation between step length (cm) and length; on left bottom corner, Correlation between step 
height (cm) and length, and on right bottom corner, Correlation between arm swing (cm) and 
length. 
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Figure 8.9 | I) Scatterplots of correlations of data gathered from the inertial sensors and 
thickness (mm) of individuals with denervation: On left top corner, Correlation between support 
phase duration (%) and thickness; on right top corner, Correlation between swing phase duration 
(%) and thickness; on middle left, Correlation between step duration (s) and thickness; on middle 
right, Correlation between step length (cm) and thickness; on left bottom corner, Correlation 
between step height (cm) and thickness, and on right bottom corner, Correlation between arm swing 
(cm) and thickness. 
